Patents by Inventor John Duncan Elliott

John Duncan Elliott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endothelin receptor antagonists
    Patent number: 6620826
    Abstract: Novel N-phenyl imidazole derivatives, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Grant
    Filed: January 29, 2003
    Date of Patent: September 16, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Joseph Weinstock, Jia-Ning Xiang
  • Endothelin receptor antagonists
    Publication number: 20030153567
    Abstract: Novel N-phenyl imidazole derivatives, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Application
    Filed: January 29, 2003
    Publication date: August 14, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Joseph Weinstock, Jia-Ning Xiang
  • Endothelin receptor antagonists
    Patent number: 6545031
    Abstract: Novel pyrroles, pyrazoles and triazoles, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists as described.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: April 8, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Juan Ignacio Luengo, John Duncan Elliott, Jia-Ning Xiang
  • Endothelin receptor antagonists
    Publication number: 20030004202
    Abstract: Novel N-phenyl imidazole derivatives, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Application
    Filed: April 30, 2002
    Publication date: January 2, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Joseph Weinstock, Jia-Ning Xiang
  • Endothelin receptor antagonists
    Patent number: 6482956
    Abstract: Novel pyrroles, pyrazoles and triazoles, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: November 19, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Juan Ignacio Luengo, John Duncan Elliott
  • Endothelin receptor antagonists
    Patent number: 6448260
    Abstract: Novel indane and indene derivatives are described which are endothelin receptor antagonists.
    Type: Grant
    Filed: July 10, 2001
    Date of Patent: September 10, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Russell Donovan Cousins, John Duncan Elliott, Maria Amparo Lago, Jack Dale Leber, Catherine Elizabeth Peishoff
  • Endothelin receptor antagonists
    Publication number: 20020072614
    Abstract: Novel pyrroles, pyrazoles and triazoles, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Application
    Filed: November 30, 2001
    Publication date: June 13, 2002
    Inventors: Juan Ignacio Luengo, John Duncan Elliott
  • Endothelin receptor antagonists
    Patent number: 6353116
    Abstract: Novel pyrroles, pyrazoles and triazoles, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Grant
    Filed: December 14, 1999
    Date of Patent: March 5, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Juan Ignacio Luengo, John Duncan Elliott
  • Endothelin receptor antagonists
    Publication number: 20020002177
    Abstract: Novel indane and indene derivatives are described which are endothelin receptor antagonists.
    Type: Application
    Filed: July 10, 2001
    Publication date: January 3, 2002
    Applicant: SmithKline Beecham Corporation
    Inventors: Russell Donovan Cousins, John Duncan Elliott, Maria Amparo Lago, Jack Dale Leber, Catherine Elizabeth Peishoff
  • Endothelin receptor antagonists
    Patent number: 6274737
    Abstract: Novel indane and indene derivatives are described which are endothelin receptor antagonists.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: August 14, 2001
    Assignee: SmithKline Beecham Corporation
    Inventors: Russell Donovan Cousins, John Duncan Elliott, Maria Amparo Lago, Jack Dale Leber, Catherine Elizabeth Peishoff
  • Endothelin receptor antagonists
    Patent number: 6271399
    Abstract: Indane and indene compounds are described which are endothelin receptor antagonists.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: August 7, 2001
    Assignee: SmithKline Beecham Corporation
    Inventors: Russell Donovan Cousins, John Duncan Elliott, Maria Amparo Lago, Jack Dale Leber, Catherine Elizabeth Peishoff
  • Endothelin receptor antagonists
    Patent number: 6174906
    Abstract: Novel to isooxazoles, oxazoles, thiazoles, isothiazoles and imidazoles, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Grant
    Filed: October 1, 1999
    Date of Patent: January 16, 2001
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Juan Ignacio Luengo, Jia-Ning Xiang
  • Phenyl derivatives useful as endothelin receptor antagonists
    Patent number: 6147111
    Abstract: Novel phenyl derivatives which are useful as endothelin receptor antagonists.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: November 14, 2000
    Assignees: SmithKline Beecham p.l.c., SmithKline Beecham Corporation
    Inventors: Jia-Ning Xiang, David Timothy MacPherson, David Francis Corbett, John Duncan Elliott
  • Endothelin receptor antagonists
    Patent number: 6136828
    Abstract: Novel isooxazoles, oxazoles, thiazoles, isothiazoles and imidazoles, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: October 24, 2000
    Assignee: SmithKline Beecham Corporation
    Inventor: John Duncan Elliott
  • Endothelin receptor antagonists
    Patent number: 6127371
    Abstract: Novel indane and indene derivatives are described which are endothelin receptor antagonists.
    Type: Grant
    Filed: October 1, 1999
    Date of Patent: October 3, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Deborah Lynne Bryan
  • Endothelin receptor antagonists
    Patent number: 6114359
    Abstract: Novel pyrroles, pyrazoles and triazoles, pharmaceutical compositions containing these compounds and their use as endothelin receptor agonists are described.
    Type: Grant
    Filed: December 6, 1999
    Date of Patent: September 5, 2000
    Assignee: SmithKline Beecham Corporation
    Inventor: John Duncan Elliott
  • Cannabinoid receptor modulators
    Patent number: 6100259
    Abstract: Novel pyrazole derivatives are provided which are cannabinoid receptor modulators.
    Type: Grant
    Filed: October 15, 1999
    Date of Patent: August 8, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: Jia-Ning Xiang, John Duncan Elliott, Steven Todd Atkinson, Siegfried Benjamin Christensen, IV
  • Endothelin receptor antagonists
    Patent number: 6096897
    Abstract: Novel pyrroles, pyrazoles and triazoles, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Grant
    Filed: June 29, 1999
    Date of Patent: August 1, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: Juan Ignacio Luengo, John Duncan Elliott
  • Endothelin receptor antagonists
    Patent number: 6087389
    Abstract: Novel indane and indene derivatives are described which are endothelin receptor antagonists.
    Type: Grant
    Filed: June 18, 1998
    Date of Patent: July 11, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: Russell Donovan Cousins, John Duncan Elliott, Maria Amparo Lago, Jack Dale Leber, Catherine Elizabeth Peishoff
  • Endothelin receptor antagonists
    Patent number: 6075037
    Abstract: Pyrrolo[2,3-b]pyridine derivatives are described which are endothelin receptor antagonists.
    Type: Grant
    Filed: November 25, 1996
    Date of Patent: June 13, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Jack Dale Leber